How to Best Define Target Populations of Medicines in View of Their Coverage by the National Health Insurance Scheme?Françoise F. Hamers, Jacques Massol, Patricia Maillère et participants of Round Table n°5 of Giens XXVTherapie, 65 4 (2010) 341-345DOI: https://doi.org/10.2515/therapie/2010034
